Emphasizing the value of phenotyping in patients receiving tamoxifen

J Clin Oncol. 2012 Feb 1;30(4):464; author reply 465. doi: 10.1200/JCO.2011.38.8892. Epub 2011 Dec 19.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / pharmacokinetics*
  • Breast Neoplasms / drug therapy*
  • Cytochrome P-450 CYP2D6 / genetics*
  • Dextromethorphan*
  • Female
  • Humans
  • Tamoxifen / analogs & derivatives*
  • Tamoxifen / pharmacokinetics*

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen
  • Dextromethorphan
  • Cytochrome P-450 CYP2D6